Vanguard Group
WVE icon

Vanguard Group’s Wave Life Sciences WVE Stock Holding History

Vanguard Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$60.8M Buy
3,573,746
+433,910
+14% +$4.41M ﹤0.01% 2067
2025
Q3 		$23M Sell
3,139,836
-337,241
-10% -$2.73M ﹤0.01% 2551
2025
Q2 		$22.6M Buy
3,477,077
+270,674
+8% +$1.79M ﹤0.01% 2503
2025
Q1 		$25.9M Buy
3,206,403
+23,891
+0.8% +$261K ﹤0.01% 2397
2024
Q4 		$39.4M Buy
3,182,512
+294,956
+10% +$3.94M ﹤0.01% 2267
2024
Q3 		$23.7M Buy
2,887,556
+469,866
+19% +$2.81M ﹤0.01% 2512
2024
Q2 		$12.1M Buy
2,417,690
+583,600
+32% +$3.33M ﹤0.01% 2810
2024
Q1 		$11.3M Buy
1,834,090
+521,665
+40% +$2.61M ﹤0.01% 2889
2023
Q4 		$6.63M Buy
1,312,425
+129,823
+11% +$694K ﹤0.01% 3170
2023
Q3 		$6.8M Buy
1,182,602
+28,401
+2% +$130K ﹤0.01% 3115
2023
Q2 		$4.2M Buy
1,154,201
+235,091
+26% +$950K ﹤0.01% 3388
2023
Q1 		$3.98M Sell
919,110
-22,452
-2% -$103K ﹤0.01% 3408
2022
Q4 		$6.59M Buy
941,562
+75,199
+9% +$347K ﹤0.01% 3163
2022
Q3 		$3.13M Buy
866,363
+145,191
+20% +$481K ﹤0.01% 3566
2022
Q2 		$2.34M Sell
721,172
-181,674
-20% -$349K ﹤0.01% 3737
2022
Q1 		$1.81M Buy
902,846
+5,819
+0.6% +$14.3K ﹤0.01% 3996
2021
Q4 		$2.82M Buy
897,027
+56,378
+7% +$234K ﹤0.01% 3909
2021
Q3 		$4.12M Buy
840,649
+56,203
+7% +$341K ﹤0.01% 3779
2021
Q2 		$5.22M Sell
784,446
-52,199
-6% -$341K ﹤0.01% 3578
2021
Q1 		$4.69M Buy
836,645
+19,338
+2% +$186K ﹤0.01% 3564
2020
Q4 		$6.43M Buy
817,307
+344,475
+73% +$2.89M ﹤0.01% 3229
2020
Q3 		$4.01M Buy
472,832
+45,817
+11% +$502K ﹤0.01% 3259
2020
Q2 		$4.45M Buy
427,015
+14,919
+4% +$140K ﹤0.01% 3148
2020
Q1 		$3.86M Buy
412,096
+1,348
+0.3% +$11.5K ﹤0.01% 3078
2019
Q4 		$3.29M Sell
410,748
-666
-0.2% -$16.3K ﹤0.01% 3308
2019
Q3 		$8.45M Buy
411,414
+18,526
+5% +$425K ﹤0.01% 2904
2019
Q2 		$10.3M Sell
392,888
-1,328
-0.3% -$37.2K ﹤0.01% 2843
2019
Q1 		$15.3M Buy
394,216
+66,786
+20% +$2.71M ﹤0.01% 2625
2018
Q4 		$13.8M Buy
327,430
+17,665
+6% +$786K ﹤0.01% 2612
2018
Q3 		$15.5M Buy
309,765
+16,794
+6% +$758K ﹤0.01% 2703
2018
Q2 		$11.2M Buy
292,971
+25,777
+10% +$1.11M ﹤0.01% 2848
2018
Q1 		$10.7M Buy
267,194
+5,424
+2% +$228K ﹤0.01% 2796
2017
Q4 		$9.19M Buy
261,770
+33,899
+15% +$988K ﹤0.01% 2861
2017
Q3 		$4.96M Buy
227,871
+12,180
+6% +$245K ﹤0.01% 3123
2017
Q2 		$4.01M Buy
215,691
+61,910
+40% +$1.33M ﹤0.01% 3167
2017
Q1 		$4.23M Buy
153,781
+7,550
+5% +$211K ﹤0.01% 3120
2016
Q4 		$3.82M Buy
146,231
+24,033
+20% +$782K ﹤0.01% 3153
2016
Q3 		$3.97M Buy
122,198
+4,337
+4% +$102K ﹤0.01% 3120
2016
Q2 		$2.44M Buy
117,861
+15,295
+15% +$238K ﹤0.01% 3307
2016
Q1 		$1.42M Buy
+102,566
New +$1.43M ﹤0.01% 3491

Other funds holding WVE

GP
GSK plc London $599M AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Vanguard Group's WVE Position: Q4 2025 in Review

Vanguard Group increased its Wave Life Sciences (WVE) stake by 14% in Q4 2025, buying an estimated $4.41M and bringing the position to 3,573,746 shares worth $60.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2067.

Vanguard Group first reported a position in WVE in Q1 2016 and has held it in 40 quarters since. 218 funds tracked by Wall St. Rank hold WVE as of Q4 2025.

  • Vanguard Group held 3,573,746 shares of Wave Life Sciences worth $60.8M as of Q4 2025.
  • Vanguard Group bought 433,910 Wave Life Sciences shares in Q4 2025, an estimated $4.41M.
  • Wave Life Sciences made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2067 holding.
  • Vanguard Group first reported a position in Wave Life Sciences in Q1 2016 and has held it in 40 quarters since.
  • 218 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.